Advanced PET scans reveal that late-life depression and bipolar disorder may signal early neurodegenerative changes before dementia symptoms emerge.
Key Details
- 1Study involved 52 late-life mood disorder (LLMD) patients and 47 controls using PET imaging for tau and amyloid proteins.
- 2~50% of LLMD patients showed abnormal tau accumulation vs. 15% of controls; 29% had amyloid vs. 2% of controls.
- 3Autopsy of 208 brain cases confirmed higher tau-related pathologies in those with late-life mood symptoms.
- 4Pathological protein buildup detectable an average of 7.3 years before cognitive or motor symptoms.
- 5Study used two PET tracers to capture diverse tau and amyloid pathologies.
- 6Findings support tau-PET as a tool for early detection of neurodegenerative diseases in psychiatric populations.
Why It Matters
These findings advance the role of molecular PET imaging in diagnosing neurodegenerative diseases at the preclinical stage—especially in patients with mood disorders—enabling earlier interventions and reshaping the clinical approach to late-onset psychiatric presentations.
Source
EurekAlert
Related News
•EurekAlert
New VIS-Fb Nanobody Probes Transform High-Precision Cellular Imaging
Salk and Einstein researchers have developed visible-spectrum antigen-stabilizable fluorescent nanobodies (VIS-Fbs) for sharper, multi-color live-cell imaging with minimal background noise.
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.